RU98123954A - Alkyl substituted cyclic amines as selective D3-dopamine ligands - Google Patents
Alkyl substituted cyclic amines as selective D3-dopamine ligandsInfo
- Publication number
- RU98123954A RU98123954A RU98123954/04A RU98123954A RU98123954A RU 98123954 A RU98123954 A RU 98123954A RU 98123954/04 A RU98123954/04 A RU 98123954/04A RU 98123954 A RU98123954 A RU 98123954A RU 98123954 A RU98123954 A RU 98123954A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- compound according
- aryl
- alkylaryl
- hydrogen
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 title claims 7
- 230000027455 binding Effects 0.000 title 1
- 229940042397 direct acting antivirals Cyclic amines Drugs 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 24
- 229910052739 hydrogen Inorganic materials 0.000 claims 16
- 125000003118 aryl group Chemical group 0.000 claims 11
- 239000001257 hydrogen Substances 0.000 claims 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 125000002877 alkyl aryl group Chemical group 0.000 claims 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- 239000000460 chlorine Substances 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 201000002674 obstructive nephropathy Diseases 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- VYXPNQWWRFIRQU-UHFFFAOYSA-N 2-(dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5-carboxamide Chemical compound CCOC1=C(C(N)=O)C=C2CC(N(CCC)CCC)CC2=C1 VYXPNQWWRFIRQU-UHFFFAOYSA-N 0.000 claims 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229920000728 polyester Polymers 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Claims (24)
где X и Y находятся в положении 5, 6 или 7, где
i) n=1, тогда Х представляет (СН2)mCONR4R5, (СН2)mSO2R3, (CH2)mSO2NR4R5, (CH2)mNR4CONHR5, (СН2)mNHSO2R3, (СН2)mNHCOR3 или C(O)R4 (где m=0 или 1, за исключением того, что если m=0, то Y не может быть водородом или галогеном) и Y представляет R4 (СН2)pCONR4R5, (СН2)pCN,
(CH2)pSO2NR4R5, OR6, (CH2)pSO2R3, (СН2)pNHSO2R3, галоген или (CH2)pNHCOR3, где р=0 или 1;
ii) n=0 или 1, тогда X u Y в о-положении относительно друг друга вместе образуют: а) (CO)NR10C(O)-, b) -C(O)NR4(CH2)xNR10C(O)-, гдe х=0 или 1, с) -CH2NR10C(O)-, d) -(GH2)2NR10C(O)-, e) -CH2C(O)NR10-, f) - N(R3)-C(O)-N(R3)-, g) -N(R3)-С(O)-O-, h) -N=C(R7)-N(R3)- или J) -CH2N(R8)CH2-; или
(iii) n= 0 и Y представляет OR9 тогда X представляет (CH2)mCONR4R5, (CH2)mSO2NR4R5, (CH2)mNR4CONHR5, (CH2)mSO2R3, (CH2)mNHSO2R3, (CH2)mNHCOR3 или C(O)R4, где m=0 или 1; R1 и R2 представляют, независимо, Н, C1-С8-алкил, или C1-С8-алкиларил; R3 представляет С1-С8-алкил, С1-С6-алкиларил или арил; R4 и R5 представляют, независимо, Н, С1-С8-алкил, С1-С6-алкиларил или арил; R6 представляет Н, С1-С8-алкил, С1-С6-алкиларил: арил-SO2СF3, SO2-C1-С8-алкил, SO2-С1-С6-алкиларил, SO2-арил; R7 представляет водород, CON(R4)2, SO2N(R4)2 или SO2R4; R8 представляет С1-С8-алкил,
С1-С6-алкиларил, арил, CON(R4)2, СОR4, SO2N(R4)2 или SO2R4 (при условии, что R4 не является водородом в каждом случае); R9 представляет С2-С8-алкил (необязательно замещенный от 1 до 3 галогенами), С1-С6-алкиларил или арил и R10 представляет Н, С1-С8-алкил, С1-С6-алкиларил, арил или (СН2)0-6SO2-арил.1. The compound of structural formula I or its pharmaceutically acceptable salts
where X and Y are in position 5, 6 or 7, where
i) n = 1, then X is (CH 2 ) m CONR 4 R 5 , (CH 2 ) m SO 2 R 3 , (CH 2 ) m SO 2 NR 4 R 5 , (CH 2 ) m NR 4 CONHR 5 , (CH 2 ) m NHSO 2 R 3 , (CH 2 ) m NHCOR 3 or C (O) R 4 (where m = 0 or 1, except that if m = 0, then Y cannot be hydrogen or halogen) and Y represents R 4 (CH 2 ) p CONR 4 R 5 , (CH 2 ) p CN,
(CH 2 ) p SO 2 NR 4 R 5 , OR 6 , (CH 2 ) p SO 2 R 3 , (CH 2 ) p NHSO 2 R 3 , halogen or (CH 2 ) p NHCOR 3 , where p = 0 or one;
ii) n = 0 or 1, then X u Y in the o-position relative to each other together form: a) (CO) NR 10 C (O) -, b) -C (O) NR 4 (CH 2 ) x NR 10 C (O) -, where x = 0 or 1, s) -CH 2 NR 10 C (O) -, d) - (GH 2 ) 2 NR 10 C (O) -, e) -CH 2 C ( O) NR 10 -, f) - N (R 3 ) -C (O) -N (R 3 ) -, g) -N (R 3 ) -C (O) -O-, h) -N = C (R 7 ) -N (R 3 ) - or J) -CH 2 N (R 8 ) CH 2 -; or
(iii) n = 0 and Y is OR 9 then X is (CH 2 ) m CONR 4 R 5 , (CH 2 ) m SO 2 NR 4 R 5 , (CH 2 ) m NR 4 CONHR 5 , (CH 2 ) m SO 2 R 3 , (CH 2 ) m NHSO 2 R 3 , (CH 2 ) m NHCOR 3 or C (O) R 4 , where m = 0 or 1; R 1 and R 2 are independently H, C 1 -C 8 -alkyl, or C 1 -C 8 -alkylaryl; R 3 is C 1 -C 8 -alkyl, C 1 -C 6 -alkylaryl or aryl; R 4 and R 5 are independently H, C 1 -C 8 -alkyl, C 1 -C 6 -alkylaryl or aryl; R 6 is H, C 1 -C 8 -alkyl, C 1 -C 6 -alkylaryl: aryl-SO 2 СF 3 , SO 2 -C 1 -C 8 -alkyl, SO 2 -C 1 -C 6 -alkylaryl, SO 2 -aryl; R 7 is hydrogen, CON (R 4 ) 2 , SO 2 N (R 4 ) 2 or SO 2 R 4 ; R 8 is C 1 -C 8 -alkyl,
C 1 -C 6 -alkylaryl, aryl, CON (R 4 ) 2 , COR 4 , SO 2 N (R 4 ) 2 or SO 2 R 4 (provided that R 4 is not hydrogen in each case); R 9 is C 2 -C 8 -alkyl (optionally substituted with 1 to 3 halogens), C 1 -C 6 alkylaryl or aryl, and R 10 is H, C 1 -C 8 alkyl, C 1 -C 6 alkylaryl , aryl or (CH 2 ) 0-6 SO 2 -aryl.
где один из А, В, С или D представляет азот и остальные положения представляют СН;
n=1 или 2;
X и Y:
i) замещены в положениях А, В, С или D, где Х представляет (CH2)mCONR4R5 (CH2)mCN, (СН2)mSO2NR4R5, OSO2R3, (CH2)mCONHR5, (CH2)mSO2R3,
(CH2)mNHSO2R3 или R1 представляет С1-С8-алкил, С1-С8-алкиларил или арил; R4 и R5, независимо, представляют Н, С1-С8-алкил, С1-С6-алкиларил или арил.16. The compound of structural formula II or its pharmaceutically acceptable salts
where one of A, B, C or D is nitrogen and the remaining positions are CH;
n = 1 or 2;
X and Y:
i) substituted in positions A, B, C or D, where X is (CH 2 ) m CONR 4 R 5 (CH 2 ) m CN, (CH 2 ) m SO 2 NR 4 R 5 , OSO 2 R 3 , (( CH 2 ) m CONHR 5 , (CH 2 ) m SO 2 R 3 ,
(CH 2 ) m NHSO 2 R 3 or R 1 is C 1 -C 8 alkyl, C 1 -C 8 alkylaryl, or aryl; R 4 and R 5 , independently, represent H, C 1 -C 8 -alkyl, C 1 -C 6 -alkylaryl or aryl.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1879496P | 1996-05-31 | 1996-05-31 | |
US60/018,794 | 1996-05-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU98123954A true RU98123954A (en) | 2000-11-20 |
RU2185372C2 RU2185372C2 (en) | 2002-07-20 |
Family
ID=21789817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU98123954/04A RU2185372C2 (en) | 1996-05-31 | 1997-05-12 | Alkyl-substituted cyclic amines as selective ligands of d3-dopamine |
Country Status (22)
Country | Link |
---|---|
US (1) | US6084130A (en) |
EP (1) | EP0923542B1 (en) |
JP (1) | JP2000511529A (en) |
KR (1) | KR20000016147A (en) |
CN (1) | CN1159292C (en) |
AT (1) | ATE247639T1 (en) |
AU (1) | AU720414B2 (en) |
CA (1) | CA2255612A1 (en) |
CZ (1) | CZ370198A3 (en) |
DE (1) | DE69724259T2 (en) |
DK (1) | DK0923542T3 (en) |
ES (1) | ES2205227T3 (en) |
FI (1) | FI982572A (en) |
HK (1) | HK1019326A1 (en) |
NO (1) | NO314398B1 (en) |
NZ (1) | NZ332538A (en) |
PL (1) | PL187296B1 (en) |
PT (1) | PT923542E (en) |
RU (1) | RU2185372C2 (en) |
SI (1) | SI0923542T1 (en) |
SK (1) | SK282725B6 (en) |
WO (1) | WO1997045403A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR022230A1 (en) * | 1999-01-12 | 2002-09-04 | Abbott Gmbh & Co Kg | TRIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND USE OF THE SAME TO PREPARE SUCH COMPOSITION |
EP1088821A1 (en) * | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives |
DE60101091T2 (en) | 2000-02-22 | 2004-07-29 | Pharmacia & Upjohn Co., Kalamazoo | (2S) AMINOIN DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS SELECTIVE DOPAMINE D3 LIGANDS |
AU2001288329A1 (en) * | 2000-09-18 | 2002-04-02 | Pharmacia Ab | Process to prepare (2s)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1h-indene-5- carboxamide |
EP1193268A1 (en) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
HU227543B1 (en) | 2001-09-28 | 2011-08-29 | Richter Gedeon Nyrt | N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them |
JP2005517705A (en) * | 2002-02-13 | 2005-06-16 | グラクソ グループ リミテッド | Benzenesulfonamide derivatives and their use as dopamine D3 and D2 receptor ligands |
EP2371814A1 (en) * | 2004-10-14 | 2011-10-05 | Abbott GmbH & Co. KG | Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
CN101039900B (en) | 2004-10-14 | 2012-03-21 | 艾博特股份有限两合公司 | 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
JP4904277B2 (en) | 2004-10-14 | 2012-03-28 | アボット ゲーエムベーハー ウント カンパニー カーゲー | Heterocyclic compounds suitable for the treatment of disorders responsive to modulation of dopamine D3 receptors |
US7834048B2 (en) | 2004-10-14 | 2010-11-16 | Abbott Gmbh & Co. Kg | Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
EP1812416B1 (en) * | 2004-10-14 | 2013-08-21 | Abbott GmbH & Co. KG | Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
ES2363348T3 (en) * | 2004-10-14 | 2011-08-01 | ABBOTT GMBH & CO. KG | SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS WITH AMINOMETILO SUITABLE TO TREAT DISORDERS THAT RESPOND TO THE MODULATION OF DOPAMINE D3 RECEIVER. |
TW200800959A (en) * | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
GB0512099D0 (en) * | 2005-06-14 | 2005-07-20 | Glaxo Group Ltd | Compounds |
WO2006138549A1 (en) * | 2005-06-17 | 2006-12-28 | Wyeth | Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists |
US20080262228A1 (en) * | 2006-11-28 | 2008-10-23 | Wyeth | Metabolites of 5-fluoro-8- quinoline and methods of preparation and uses thereof |
GB0721333D0 (en) * | 2007-10-31 | 2007-12-12 | Motac Neuroscience Ltd | Medicaments |
GB0721332D0 (en) * | 2007-10-31 | 2007-12-12 | Motac Neuroscience Ltd | Medicaments |
CN102786483B (en) * | 2011-05-19 | 2016-03-30 | 复旦大学 | 4-(4-Phenylpiperazinyl) pharmaceutical usage of quinazoline derivative |
CN106715395B (en) * | 2014-07-30 | 2020-05-12 | 豪夫迈·罗氏有限公司 | 6-amino-5, 6, 7, 8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives as TAAR modulators |
WO2018200571A1 (en) | 2017-04-25 | 2018-11-01 | Arbutus Biopharma Corporation | Substituted 2,3-dihydro-1h-indene analogs and methods using same |
CN110041318B (en) * | 2018-01-17 | 2022-07-29 | 中国科学院上海药物研究所 | Dopamine D5 receptor agonist and preparation and application thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2752659A1 (en) * | 1976-12-07 | 1978-06-08 | Sandoz Ag | NEW TETRALINE DERIVATIVES, THEIR PRODUCTION AND USE |
FR2512814A1 (en) * | 1981-09-16 | 1983-03-18 | Synthelabo | AMINO-2-TETRAHYDRO-1,2,3,4-NAPHTHALENE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
US4448990A (en) * | 1982-11-16 | 1984-05-15 | Eli Lilly And Company | Hydroxyaminotetralincarboxamides |
JPS6169747A (en) * | 1984-08-31 | 1986-04-10 | Otsuka Pharmaceut Co Ltd | 2,3-dihydro-1h-indene derivative |
EP0186087B1 (en) * | 1984-12-22 | 1989-08-23 | Dr. Karl Thomae GmbH | Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs |
DE3719924A1 (en) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-SUBSTITUTED 2-AMINOTETRALINE |
US5225596A (en) * | 1989-01-09 | 1993-07-06 | The Upjohn Company | Halo substituted aminotetralins |
DK0690843T3 (en) * | 1993-03-25 | 2000-11-13 | Upjohn Co | Pre-nyl or cyano-substituted indole derivatives with dopaninergic activity |
DE69422044T2 (en) * | 1993-08-06 | 2000-05-31 | Upjohn Co | 2-AMINOINDANE AS SELECTIVE DOPAMINE D3 LIGANDS |
HU224354B1 (en) * | 1995-02-01 | 2005-08-29 | Pharmacia & Upjohn Company | Use of 2-aminoindan derivatives and pharmaceutical compositions containing them |
JPH11503116A (en) * | 1995-03-27 | 1999-03-23 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Bicyclic amine derivatives and their use as antipsychotics |
-
1997
- 1997-05-12 EP EP97925470A patent/EP0923542B1/en not_active Expired - Lifetime
- 1997-05-12 KR KR1019980709715A patent/KR20000016147A/en not_active Application Discontinuation
- 1997-05-12 CZ CZ983701A patent/CZ370198A3/en unknown
- 1997-05-12 DE DE69724259T patent/DE69724259T2/en not_active Expired - Fee Related
- 1997-05-12 WO PCT/US1997/007650 patent/WO1997045403A1/en not_active Application Discontinuation
- 1997-05-12 CA CA002255612A patent/CA2255612A1/en not_active Abandoned
- 1997-05-12 ES ES97925470T patent/ES2205227T3/en not_active Expired - Lifetime
- 1997-05-12 DK DK97925470T patent/DK0923542T3/en active
- 1997-05-12 PT PT97925470T patent/PT923542E/en unknown
- 1997-05-12 RU RU98123954/04A patent/RU2185372C2/en not_active IP Right Cessation
- 1997-05-12 CN CNB971943265A patent/CN1159292C/en not_active Expired - Fee Related
- 1997-05-12 JP JP09542424A patent/JP2000511529A/en not_active Ceased
- 1997-05-12 SI SI9730586T patent/SI0923542T1/en unknown
- 1997-05-12 AU AU30601/97A patent/AU720414B2/en not_active Ceased
- 1997-05-12 SK SK1488-98A patent/SK282725B6/en unknown
- 1997-05-12 AT AT97925470T patent/ATE247639T1/en not_active IP Right Cessation
- 1997-05-20 US US08/859,587 patent/US6084130A/en not_active Expired - Fee Related
-
1998
- 1998-11-02 PL PL97330207A patent/PL187296B1/en not_active IP Right Cessation
- 1998-11-02 NZ NZ332538A patent/NZ332538A/en unknown
- 1998-11-27 FI FI982572A patent/FI982572A/en not_active IP Right Cessation
- 1998-11-30 NO NO19985599A patent/NO314398B1/en not_active Application Discontinuation
-
1999
- 1999-10-08 HK HK99104438A patent/HK1019326A1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU98123954A (en) | Alkyl substituted cyclic amines as selective D3-dopamine ligands | |
CO4900002A1 (en) | N- (TRIAZOLOAZINYL) ARYL SULFONAMIDE COMPOUNDS. | |
YU17591A (en) | TRIAZOLNI FUNGICIDNI AGENCY | |
NO164350C (en) | AZOLYL DERIVATIVES, ANTISOPP PREPARATIONS, AND USE OF THE COMPOUNDS FOR COMBATING SOPPIN INFECTIONS. | |
RU94036774A (en) | INHIBITION OF PROLIFERATION OF SMOOTH MUSCLE CELLS AND RESTENOSIS | |
MX9102766A (en) | NEW SULPHONATED XANTHINES AND PROCEDURE FOR SUN NEW SULPHONE XANTHINES AND PROCEDURE FOR THEIR PREPARATION. PREPARATION. | |
JP2003511415A5 (en) | ||
RU93056600A (en) | PHENOXY- AND PHENOXIALKYLPIPERIDINE COMPOUNDS AND ANTI-VIRUS COMPOSITION | |
NO20045327L (en) | Chemical connections | |
SE7704039L (en) | SUBSTITUTED PHENOXY BENZYLOXICARBONYL DERIVATIVES USED AS INSECTICIDES AND ACARICIDES, AND FOR THEIR PREPARATION | |
EA199901102A1 (en) | DERIVATIVES OF AZETIDINILPROPILPIPERIDINE, INTERMEDIATE CONNECTIONS AND APPLICATION AS ANTAGONISTS OF TAKHIKININ | |
SE8406302L (en) | NEW AMINOGUANIDE DERIVATIVES AND A PROCEDURE FOR THEIR PREPARATION | |
ES552044A0 (en) | A PROCEDURE FOR THE PREPARATION OF TRICYCLIC OXINDOL-CARBOXAMIDES | |
ATE19620T1 (en) | DICHLORAMINOACID DERIVATIVES WITH GERMICIDAL AND FUNGICIDAL ACTIVITIES. | |
RU2001121162A (en) | The method of obtaining derivatives of pyrazolo [4,3-D] pyrimidin-7-one and intermediates | |
RU94011565A (en) | THIOXANTENONE COMPOUNDS, THEIR USE, ANTI-SMALL COMPOSITION | |
GB1479562A (en) | 4,4'-diheterocyclic substituted stilbenes and their use as optical brighteners | |
ES514634A0 (en) | "A PROCEDURE FOR THE PREPARATION OF 2- (1,4-BENZODIOXAN-2-IL-METHYL) -IMIDAZOLINE". | |
DK0782574T3 (en) | Bicyclic carboxyamides as 5-HT1A receptor ligands | |
KR850002255A (en) | Process for preparing substituted imidazolinyl benzoic acid, esters and salts | |
AR022809A1 (en) | DERIVATIVES OF CICLOBUTEN-3,4-DIONA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS | |
CO5170406A1 (en) | RECEIVER LIGANDS FOR C3A TOR FOR C3A and antigonizing methods OF THE SAME | |
FI841408A (en) | FOERFARANDE FOER FRAMSTAELLNING AV 4- ACETYL-2-SUBSTITUERADE-IMIDAZOLER OCH I FOERFARANDET ANVAENDA MELLANPRODUKTER. | |
CO5180549A1 (en) | DERIVATIVES OF 1-AMINO ETHYLINDOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS | |
EP0011821A3 (en) | Antiseborrhoeic hair treatment composition |